Akero Therapeutics Inc (AKRO)
20.53
-1.07
(-4.95%)
USD |
NASDAQ |
Apr 18, 16:00
20.53
0.00 (0.00%)
After-Hours: 20:00
Akero Therapeutics Price to Book Value: 2.644 for April 18, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 17, 2024 | 2.782 |
| April 16, 2024 | 2.807 |
| April 15, 2024 | 2.798 |
| April 12, 2024 | 2.857 |
| April 11, 2024 | 2.813 |
| April 10, 2024 | 2.821 |
| April 09, 2024 | 3.058 |
| April 08, 2024 | 2.979 |
| April 05, 2024 | 2.991 |
| April 04, 2024 | 2.958 |
| April 03, 2024 | 2.986 |
| April 02, 2024 | 3.011 |
| April 01, 2024 | 3.100 |
| March 28, 2024 | 3.254 |
| March 27, 2024 | 3.149 |
| March 26, 2024 | 3.141 |
| March 25, 2024 | 3.113 |
| March 22, 2024 | 3.237 |
| March 21, 2024 | 3.341 |
| March 20, 2024 | 3.244 |
| March 19, 2024 | 3.330 |
| March 18, 2024 | 3.457 |
| March 15, 2024 | 3.547 |
| March 14, 2024 | 3.525 |
| March 13, 2024 | 3.602 |
| Date | Value |
|---|---|
| March 12, 2024 | 3.666 |
| March 11, 2024 | 3.775 |
| March 08, 2024 | 4.016 |
| March 07, 2024 | 3.248 |
| March 06, 2024 | 3.155 |
| March 05, 2024 | 3.210 |
| March 04, 2024 | 3.268 |
| March 01, 2024 | 2.925 |
| February 29, 2024 | 2.838 |
| February 28, 2024 | 2.864 |
| February 27, 2024 | 2.871 |
| February 26, 2024 | 2.514 |
| February 23, 2024 | 2.665 |
| February 22, 2024 | 2.522 |
| February 21, 2024 | 2.504 |
| February 20, 2024 | 2.252 |
| February 16, 2024 | 2.176 |
| February 15, 2024 | 2.230 |
| February 14, 2024 | 2.265 |
| February 13, 2024 | 2.144 |
| February 12, 2024 | 2.279 |
| February 09, 2024 | 2.058 |
| February 08, 2024 | 1.937 |
| February 07, 2024 | 1.863 |
| February 06, 2024 | 1.850 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.087
Minimum
Oct 27 2023
12.74
Maximum
Jul 27 2020
4.623
Average
4.014
Median
Jan 21 2021
Price to Book Value Benchmarks
| Madrigal Pharmaceuticals Inc | 10.93 |
| 89bio Inc | 1.550 |
| Viking Therapeutics Inc | 18.66 |
| Eli Lilly and Co | 65.75 |
| Ionis Pharmaceuticals Inc | 15.37 |
Price to Book Value Related Metrics
| Price | 20.53 |
| Earnings Yield | -14.03% |
| Market Cap | 1.415B |